Viralgen's Unattributed VC Round

Viralgen raised a round of funding on October 24, 2017.

Viralgen is a gene therapy joint venture between Asklepios BioPharmaceutical (AskBio) and Columbus Venture Partners.…

Articles about Viralgen's Unattributed VC Round: